Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1976 Oct 30;13(1):31-44.
doi: 10.1007/BF01732393.

Interconversion phenomena between two kinetic forms of class a pyruvate kinase from Ehrlich ascites tumor cells

Interconversion phenomena between two kinetic forms of class a pyruvate kinase from Ehrlich ascites tumor cells

J E Felíu et al. Mol Cell Biochem. .

Abstract

1. The regulatory properties of two interconvertible kinetic forms of class A pyruvate kinase from Ehrlich ascites tumor cells have been studied with a partially purified enzyme preparation free of interfering enzymatic activities. 2. The hyperbolic form shows Michaelis-Menten kinetics for P-pyruvate, with high affinity for this substrate and low affinity for the inhibitory amino acids alanine and phenylalanine. The sigmoidal form displays positive cooperativity respect to P-pyruvate (n=1.4), with lower affinity for this substrate and higher affinity for the inhibitory amino acids. 3. The equilibrium between the hyperbolic and the sigmoidal forms of the enzyme is affected by substraetes and effectors. P-pyruvate, ADP and Fru-P2 shift the equilibrium to the hyperbolic form while ATP, alanine and phenylalanine stabilize the sigmoidal form. 4. Effector metabolites affect the molecular weight of the protein, acting on an equilibrium between dimers and tetramers. P-pyruvate and ADP associate the enzyme to a tetramer while ATP, alanine and phenylalanine favor the occurrence as a dimer. The positive modifier Fru-P2 did not associate the enzyme to the tetramer, even at 1 mM concentration. 5. A tentative molecular model for pyruvate kinase A on the basis of the kinetic and aggregation interconversion is proposed.

PubMed Disclaimer

References

    1. Arch Biochem Biophys. 1973 Aug;157(2):509-13 - PubMed
    1. J Biol Chem. 1970 Nov 10;245(21):5788-99 - PubMed
    1. Hoppe Seylers Z Physiol Chem. 1971 Mar;352(3):453-8 - PubMed
    1. Eur J Biochem. 1973 Aug 1;37(1):148-56 - PubMed
    1. J Biochem. 1972 Oct;72(4):1001-15 - PubMed